Last reviewed · How we verify
Ginkgo leaf dropping pill
Ginkgo leaf dropping pill is a Herbal extract / Traditional medicine Small molecule drug developed by Wanbangde Pharmaceutical Group Co., LTD. It is currently FDA-approved for Age-related cognitive decline and memory impairment, Cerebrovascular insufficiency, Tinnitus and vertigo.
Ginkgo leaf extract improves blood circulation and reduces blood viscosity to enhance cerebral blood flow and oxygen delivery.
Ginkgo leaf extract improves blood circulation and reduces blood viscosity to enhance cerebral blood flow and oxygen delivery. Used for Age-related cognitive decline and memory impairment, Cerebrovascular insufficiency, Tinnitus and vertigo.
At a glance
| Generic name | Ginkgo leaf dropping pill |
|---|---|
| Sponsor | Wanbangde Pharmaceutical Group Co., LTD |
| Drug class | Herbal extract / Traditional medicine |
| Modality | Small molecule |
| Therapeutic area | Neurology / Cognitive disorders |
| Phase | FDA-approved |
Mechanism of action
Ginkgo biloba leaf contains flavonoids and terpenoids that act as vasodilators and antioxidants, improving microcirculation and reducing platelet aggregation. This mechanism is thought to enhance cognitive function and reduce symptoms associated with cerebrovascular insufficiency by increasing oxygen and nutrient delivery to the brain.
Approved indications
- Age-related cognitive decline and memory impairment
- Cerebrovascular insufficiency
- Tinnitus and vertigo
Common side effects
- Gastrointestinal upset
- Headache
- Dizziness
- Bleeding risk (with anticoagulants)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ginkgo leaf dropping pill CI brief — competitive landscape report
- Ginkgo leaf dropping pill updates RSS · CI watch RSS
- Wanbangde Pharmaceutical Group Co., LTD portfolio CI
Frequently asked questions about Ginkgo leaf dropping pill
What is Ginkgo leaf dropping pill?
How does Ginkgo leaf dropping pill work?
What is Ginkgo leaf dropping pill used for?
Who makes Ginkgo leaf dropping pill?
What drug class is Ginkgo leaf dropping pill in?
What development phase is Ginkgo leaf dropping pill in?
What are the side effects of Ginkgo leaf dropping pill?
Related
- Drug class: All Herbal extract / Traditional medicine drugs
- Manufacturer: Wanbangde Pharmaceutical Group Co., LTD — full pipeline
- Therapeutic area: All drugs in Neurology / Cognitive disorders
- Indication: Drugs for Age-related cognitive decline and memory impairment
- Indication: Drugs for Cerebrovascular insufficiency
- Indication: Drugs for Tinnitus and vertigo
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing